lr

Lam Research

LRCX
NASDAQ
$252.62
84
Good

The toll‑collector on chip complexity in the AI buildout

Lam Research designs and services critical etch, deposition and clean tools that enable every advanced logic and memory node.

Over the last four reported quarters through the December 28, 2025 quarter, Lam generated about 20.6 billion dollars of revenue and 6.22 billion dollars of free cash flow, with non‑GAAP gross margin around 50 percent and operating margin about 34 percent.

Customer Support Business Group revenue tied to the installed base reached roughly 2.0 billion dollars in the December 2025 quarter and 6.94 billion dollars in fiscal 2025, giving Lam a resilient, high‑margin annuity alongside systems sales.

Lam’s installed base has grown to about 102,000 chambers, expanding upgrade, spares and services economics as process complexity rises with gate‑all‑around transistors, advanced packaging and HBM memory. The core risks are industry cyclicality and geopolitics.

China represented about 34 percent of fiscal 2025 revenue and 35 percent of the December 2025 quarter, and U.S. export controls on advanced computing and semiconductor manufacturing items continue to evolve.

Lam acknowledges this in risk factors and has indicated 2026 WFE is likely to be broad‑based across DRAM and leading‑edge foundry with China flattish as a percent of mix. Balance sheet strength, disciplined capital returns and technology leadership help offset volatility, but export rule changes remain a material swing factor.

published on April 16, 2026 (13 days ago)

Does Lam Research have a strong competitive moat?

84
Good

Lam’s durable advantage rests on process know‑how in plasma etch and thin‑film deposition, deep co‑development ties, and an expanding installed base that raises switching costs.

Evidence includes sustained 50 percent gross margin at scale, record CSBG revenue and an installed base of about 102,000 chambers that increases upgrade and spares intensity as device architectures grow more complex.

Competitive context is an oligopoly across etch and deposition where Applied Materials, Tokyo Electron, Screen and others contest share, but qualification barriers are high once a tool is integrated at a node.

Component scores and weights: Switching costs 90/100 (weight 30 percent) due to node‑level qualifications and process reuse across generations; Efficient scale 85/100 (weight 25 percent) given the concentrated WFE oligopoly and long product cycles; Intangible assets 80/100 (weight 20 percent) from IP portfolios and application libraries documented across product families like Vantex, Kiyo, ALTUS and SABRE; Cost advantage 75/100 (weight 15 percent) from learning‑curve and factory efficiency improvements; Network effects 55/100 (weight 10 percent) since collaboration ecosystems help but do not create classical user‑to‑user effects.

Weighted average yields approximately 84. Key erosion paths: competitor share gains at inflections, customer insourcing, or export rule changes that redirect demand or empower local competitors.

Does Lam Research have pricing power in its industry?

82
Good

Recent quarters show non‑GAAP gross margin around 49 to 50 percent and operating margin near 34 percent, indicating ability to price for value in critical etch and deposition steps.

Lam benefits from high differentiation in advanced etch (cryo dielectric, high aspect ratio) and selective deposition (ALD/ALTUS Halo) where yield impact is large relative to tool cost. The installed base raises recurring service and upgrade pricing leverage.

Latent pricing power persists as AI‑driven nodes and HBM packaging increase etch intensity and process steps per wafer. Offsets: government pricing constraints via export controls in certain markets and periodic concessions to win placements at new nodes.

How predictable is Lam Research's business?

68
Average

Lam participates in a cyclical WFE market, yet the revenue mix includes a growing CSBG annuity that smooths cycles.

Over the last four reported quarters Lam delivered about 20.6 billion dollars in revenue and 6.22 billion dollars of free cash flow, with CSBG at roughly 6.94 billion dollars in FY25. Management’s CY2026 WFE outlook calls for about 135 billion dollars industry spend, led by DRAM and leading‑edge foundry‑logic.

Predictability is good for services and mature nodes, but overall exposure remains tied to customer capex cycles and export licensing. Geographic concentration adds variance as China was about 34 percent of FY25 revenue and 35 percent in the most recent quarter.

Is Lam Research financially strong?

86
Good

As of December 28, 2025 Lam held about 6.2 billion dollars in cash and cash equivalents versus approximately 4.47 billion dollars of total debt at FY2025 year end, implying net cash and robust liquidity.

TTM free cash flow of about 6.22 billion dollars and capex of roughly 0.9 billion dollars indicate an asset‑light model with ample coverage for R&D, buybacks and dividends. Deferred revenue was about 2.25 billion dollars in December, providing near‑term visibility. The balance sheet and cash generation appear resilient against downturns.

How effective is Lam Research's capital allocation strategy?

88
Good

Lam consistently prioritizes high‑return internal R&D, then returns a large share of free cash flow via buybacks and a growing dividend. In FY2025 the company spent about 2.10 billion dollars on R&D, repurchased about 3.41 billion dollars of stock including a 500 million dollar ASR, and paid roughly 1.15 billion dollars in dividends.

The board raised the quarterly dividend to 0.26 dollars in August 2025 and continued it in February 2026. Management has communicated a framework to return around the vast majority of free cash flow over time. Dilution from equity compensation is modest relative to repurchases.

We view M&A discipline as sound since the Novellus merger, with focus on strengthening core process modules.

Does Lam Research have high-quality management?

82
Good

CEO Tim Archer and CFO Doug Bettinger have steered Lam through downturns and positioned it to capture AI‑driven inflections. Communication and execution quality appear high, evidenced by consistent margin delivery near or above the model and clear framing of WFE and CSBG drivers.

The team emphasizes installed base monetization, rapid ramp execution with customers and disciplined capital returns. Governance appears standard for a U.S. large cap. Not founder‑led, but strategy and incentives are aligned with long‑term free cash flow compounding.

Good

Is Lam Research a quality company?

Lam Research is a good quality company with a quality score of 84/100

84
Good
49
Average
Quality Momentum

Predicted probability of operating margin improvement over the next 12 months

  • TTM fundamentals: about 20.6 billion dollars revenue and 6.22 billion dollars free cash flow through Dec 28, 2025, with non‑GAAP gross margin near 50 percent and operating margin about 34 percent.
  • Installed base scale and switching costs: roughly 102,000 chambers drive a growing, high‑margin CSBG annuity and upgrades, supporting resilience through cycles.
  • Multi‑year AI inflections: gate‑all‑around, backside power and advanced packaging including HBM expand Lam’s served market and favor its etch and deposition franchises.
  • Geopolitical risk: China was about 34 percent of FY25 revenue and 35 percent of Dec 2025 quarter revenue; export controls remain a key uncertainty to revenue mix.
  • Shareholder alignment: 10‑for‑1 split executed in Oct 2024 and a stated framework to return a very high share of free cash flow through buybacks and dividends, with FY25 buybacks and dividends of roughly 4.57 billion dollars.

What is the fair value of Lam Research stock?

Is Lam Research a good investment at $253?

$252.62
Important Disclaimer:

The following analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment advice, or a recommendation to buy or sell any security. The opinions expressed are based on publicly available information and historical data. Beanvest and its contributors may hold positions in the securities mentioned. Investors should conduct their own due diligence or consult a licensed financial advisor before making any investment decision.

Other stocks from NASDAQ